Free Trial

MDxHealth (MDXH) Competitors

MDxHealth logo
$4.76 +0.03 (+0.63%)
Closing price 04:00 PM Eastern
Extended Trading
$4.76 +0.00 (+0.11%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDXH vs. FLGT, ZEPP, LAB, BFLY, TALK, SOPH, TBRG, OM, HCAT, and KRMD

Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include Fulgent Genetics (FLGT), Zepp Health (ZEPP), Standard BioTools (LAB), Butterfly Network (BFLY), Talkspace (TALK), SOPHiA GENETICS (SOPH), TruBridge (TBRG), Outset Medical (OM), Health Catalyst (HCAT), and KORU Medical Systems (KRMD). These companies are all part of the "medical info sys" industry.

MDxHealth vs. Its Competitors

Fulgent Genetics (NASDAQ:FLGT) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

48.1% of Fulgent Genetics shares are owned by institutional investors. 33.1% of Fulgent Genetics shares are owned by company insiders. Comparatively, 1.7% of MDxHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

MDxHealth has lower revenue, but higher earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fulgent Genetics$283.47M2.44-$42.71M-$1.66-13.63
MDxHealth$90.05M2.50-$38.07M-$0.88-5.41

In the previous week, MDxHealth had 2 more articles in the media than Fulgent Genetics. MarketBeat recorded 2 mentions for MDxHealth and 0 mentions for Fulgent Genetics. MDxHealth's average media sentiment score of 0.73 beat Fulgent Genetics' score of 0.00 indicating that MDxHealth is being referred to more favorably in the news media.

Company Overall Sentiment
Fulgent Genetics Neutral
MDxHealth Positive

Fulgent Genetics has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500.

Fulgent Genetics has a net margin of -16.83% compared to MDxHealth's net margin of -34.98%. Fulgent Genetics' return on equity of -2.26% beat MDxHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
Fulgent Genetics-16.83% -2.26% -2.10%
MDxHealth -34.98%-374.98%-21.97%

Fulgent Genetics presently has a consensus price target of $25.33, suggesting a potential upside of 11.95%. MDxHealth has a consensus price target of $7.00, suggesting a potential upside of 47.06%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts plainly believe MDxHealth is more favorable than Fulgent Genetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fulgent Genetics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
MDxHealth
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

MDxHealth beats Fulgent Genetics on 10 of the 16 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDXH vs. The Competition

MetricMDxHealthMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$223.67M$2.26B$6.12B$10.65B
Dividend YieldN/AN/A5.69%4.73%
P/E Ratio-5.4137.1985.6126.85
Price / Sales2.5012.34612.81135.18
Price / CashN/A61.3337.7861.77
Price / Book15.3512.7713.256.70
Net Income-$38.07M-$63.46M$3.30B$276.44M
7 Day Performance2.37%4.72%4.70%3.13%
1 Month Performance34.84%7.17%8.43%10.21%
1 Year Performance138.00%41.21%88.01%40.35%

MDxHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDXH
MDxHealth
3.1336 of 5 stars
$4.76
+0.6%
$7.00
+47.1%
+136.5%$223.67M$90.05M-5.41300News Coverage
Short Interest ↓
FLGT
Fulgent Genetics
3.1915 of 5 stars
$22.39
+0.4%
$25.33
+13.2%
+10.1%$686.35M$303.22M-13.511,313Positive News
ZEPP
Zepp Health
0.8429 of 5 stars
$44.62
-6.4%
$60.23
+35.0%
+1,338.5%$648.82M$182.60M-9.261,230Gap Up
LAB
Standard BioTools
2.4875 of 5 stars
$1.32
+3.5%
$1.55
+17.9%
-28.6%$502.32M$172.27M-4.11620
BFLY
Butterfly Network
2.8169 of 5 stars
$1.93
-1.8%
$3.00
+55.8%
+30.9%$484.60M$82.06M-6.88460News Coverage
Options Volume
Gap Up
TALK
Talkspace
3.8419 of 5 stars
$2.76
-0.2%
$4.50
+63.3%
+14.6%$461.38M$187.59M137.82500News Coverage
SOPH
SOPHiA GENETICS
2.474 of 5 stars
$4.73
+6.7%
$8.00
+69.2%
+23.1%$318.10M$65.17M-10.70520Short Interest ↓
TBRG
TruBridge
1.8283 of 5 stars
$20.21
-0.7%
$23.67
+17.1%
+67.7%$305.12M$345.87M-24.203,200
OM
Outset Medical
1.5533 of 5 stars
$14.01
-3.3%
$24.67
+76.1%
+59.7%$249.22M$113.69M-0.69520Positive News
HCAT
Health Catalyst
4.1514 of 5 stars
$2.86
-2.2%
$4.73
+65.6%
-61.6%$200.91M$306.58M-1.891,500Analyst Forecast
KRMD
KORU Medical Systems
2.7582 of 5 stars
$3.78
-1.7%
$4.63
+22.5%
+51.1%$174.60M$33.65M-41.9680Positive News

Related Companies and Tools


This page (NASDAQ:MDXH) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners